Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

Rhea-AI Summary

Pulmonx Corporation (NASDAQ: LUNG), a leader in minimally invasive treatments for severe lung disease, has announced its participation in the upcoming Bank of America Securities 2025 Health Care Conference. The presentation is scheduled for Wednesday, May 14, 2025, at 9:35 AM PT / 12:35 PM ET in Las Vegas. Investors and interested parties can access both the live and archived webcast of the presentation through the company's investor relations website at investors.pulmonx.com.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be presenting at the Bank of America Securities 2025 Health Care Conference in Las Vegas on Wednesday, May 14, 2025, at 9:35 AM PT / 12:35 PM ET.

A live and archived webcast of the presentation will be available on “Investors” section of the Pulmonx website at https://investors.pulmonx.com/.

About Pulmonx Corporation
Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD). Pulmonx’s Zephyr^® Endobronchial Valve, Chartis^® Pulmonary Assessment System, LungTraX^™ Platform, and StratX^® Lung Analysis Report are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received FDA pre-market approval to commercialize the Zephyr Valve following its designation as a “breakthrough device.” The Zephyr Valve is commercially available in more than 25 countries, is included in global treatment guidelines and is widely considered a standard of care treatment option for improving breathing, activity and quality of life in patients with severe emphysema. For more information on the Zephyr Valves and the company, please visit www.Pulmonx.com.

Contact
Brian Johnston
Laine Morgan
Gilmartin Group
investors@pulmonx.com

FAQ

When is Pulmonx (LUNG) presenting at the Bank of America Securities Healthcare Conference 2025?

Pulmonx (LUNG) is presenting at the Bank of America Securities Healthcare Conference on Wednesday, May 14, 2025, at 9:35 AM PT / 12:35 PM ET in Las Vegas.

How can I watch Pulmonx's (LUNG) presentation at the BofA Healthcare Conference?

The presentation can be accessed through a live and archived webcast available on the 'Investors' section of Pulmonx's website at investors.pulmonx.com.

What does Pulmonx Corporation (LUNG) specialize in?

Pulmonx Corporation (LUNG) is a global leader in minimally invasive treatments for severe lung disease.

Where is the Bank of America Securities 2025 Health Care Conference being held?

The Bank of America Securities 2025 Health Care Conference is being held in Las Vegas.